Literature DB >> 1768377

Identification of mixed HIV-1/HIV-2 infections in Brazil by polymerase chain reaction.

D Pieniazek1, J M Peralta, J A Ferreira, J W Krebs, S M Owen, F S Sion, C F Filho, A B Sereno, C A de Sa, B G Weniger.   

Abstract

Analysis of sera from hospitalized Brazilian patients by whole-virus lysate-based enzyme immunoassay and Western blot indicated that 0.4% were reactive to HIV-2 alone while 4% were reactive to both HIV-1 and HIV-2. When these sera were tested for HIV antibody by type-specific peptide enzyme immunoassays, dual seropositivity was confirmed in only 0.4% of patients. To define genetically the HIV strains within the population, we analyzed peripheral blood mononuclear cells from selected seropositive patients for the presence of HIV-1 and HIV-2 proviral DNA using the polymerase chain reaction (PCR). Independent primers/probes sets were used for the amplification and detection of viral sequences from the long terminal repeat (LTR), gag, and protease (prt) gene regions. Our findings confirmed the serologic evidence of HIV-2 in Brazil and determined the extent of mixed HIV-1 and HIV-2 infections. Detailed evaluation of the amplified viral protease sequences by endonuclease restriction analysis and DNA sequencing independently confirmed mixed HIV-1 and HIV-2 infections in the two patients seropositive for HIV-1 and HIV-2. The data further indicated that these isolates are distinct from the HIV laboratory standards. We interpret the combination of culture and PCR findings to demonstrate the presence of both HIV-1 and HIV-2 in Brazil.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1768377     DOI: 10.1097/00002030-199111000-00002

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  15 in total

1.  Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy.

Authors:  B Rodés; A Holguín; V Soriano; M Dourana; K Mansinho; F Antunes; J González-Lahoz
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Identification of single and dual infections with distinct subtypes of human immunodeficiency virus type 1 by using restriction fragment length polymorphism analysis.

Authors:  L M Janini; D Pieniazek; J M Peralta; M Schechter; A Tanuri; A C Vicente; N dela Torre; N J Pieniazek; C C Luo; M L Kalish; G Schochetman; M A Rayfield
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

3.  Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A.

Authors:  Nuno R Faria; Ioannis Hodges-Mameletzis; Joana C Silva; Berta Rodés; Smit Erasmus; Stefania Paolucci; Jean Ruelle; Danuta Pieniazek; Nuno Taveira; Ana Treviño; Maria F Gonçalves; Sabelle Jallow; Li Xu; Ricardo J Camacho; Vincent Soriano; Patrick Goubau; João D de Sousa; Anne-Mieke Vandamme; Marc A Suchard; Philippe Lemey
Journal:  J Gen Virol       Date:  2011-12-21       Impact factor: 3.891

4.  Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells.

Authors:  M Janini; M Rogers; D R Birx; F E McCutchan
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  Molecular confirmation of human immunodeficiency virus (HIV) type 2 in HIV-seropositive subjects in south India.

Authors:  R Kannangai; S Ramalingam; K J Prakash; O C Abraham; R George; R C Castillo; D H Schwartz; M V Jesudason; G Sridharan
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

6.  Detection of simian immunodeficiency virus in diverse species and of human immunodeficiency virus Type 2 by using consensus primers within the pol region.

Authors:  Silvina Masciotra; Chunfu Yang; Danuta Pieniazek; Chanda Thomas; Sherry M Owen; Harold M McClure; Renu B Lal
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

7.  The induction of in vivo superinfection and recombination using feline immunodeficiency virus as the model.

Authors:  M T Kyaw-Tanner; W K Greene; H S Park; W F Robinson
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users.

Authors:  Artur Ramos; Dale J Hu; Lily Nguyen; Kim-Oanh Phan; Suphak Vanichseni; Nattawan Promadej; Kachit Choopanya; Margaret Callahan; Nancy L Young; Janet McNicholl; Timothy D Mastro; Thomas M Folks; Shambavi Subbarao
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  Productive expression state confers resistance of human immunodeficiency virus (HIV)-2-infected lymphoma cells against superinfection by HIV-1.

Authors:  G K von Dalnok; A Kleinschmidt; M Neumann; C Leib-Moesch; V Erfle; R Brack-Werner
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Patterns of feline immunodeficiency virus multiple infection and genome divergence in a free-ranging population of African lions.

Authors:  Jennifer L Troyer; Jill Pecon-Slattery; Melody E Roelke; Lori Black; Craig Packer; Stephen J O'Brien
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.